Veterinary Medicines

PULSIX 250 mg/1250 mg spot-on solution for dogs over 10 kg up to 25 kg

Authorised
  • Imidacloprid
  • Permethrin (40:60)
Download as PDF

Product identification

Medicine name:
PULSIX 250 mg/1250 mg spot-on solution for dogs over 10 kg up to 25 kg
Pulsix (250 mg + 1250 mg)/pipetkę 2,5 ml Roztwór do nakrapiania
Active substance:
  • Imidacloprid
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    250.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin (40:60)
    1250.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • HISTORICAL Cardboard box containing 1 pipette of 2.5 ml without pouch
  • Cardboard box containing 2 pipettes of 2.5 ml with pouch
  • HISTORICAL Cardboard box containing 2 pipettes of 2.5 ml without pouch
  • Cardboard box containing 3 pipettes of 2.5 ml with pouch
  • HISTORICAL Cardboard box containing 3 pipettes of 2.5 ml without pouch
  • Cardboard box containing 4 pipettes of 2.5 ml with pouch
  • HISTORICAL Cardboard box containing 4 pipettes of 2.5 ml without pouch
  • Cardboard box containing 6 pipettes of 2.5 ml with pouch
  • HISTORICAL Cardboard box containing 6 pipettes of 2.5 ml without pouch
  • Cardboard box containing 1 pipette of 2.5 ml with pouch
  • Cardboard box containing 24 pipettes of 2.5 ml with pouch
  • HISTORICAL Cardboard box containing 24 pipettes of 2.5 ml without pouch
  • HISTORICAL Cardboard box containing 12 pipettes of 2.5 ml without pouch
  • Cardboard box containing 12 pipettes of 2.5 ml with pouch

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ab7 Sante
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ab7 Sante
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3380
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0667/003
Concerned member states:
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 28/11/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 28/11/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 28/11/2025
Download

Combined File of all Documents

English (PDF)
Published on: 26/10/2025
Download